Kiora Pharmaceuticals, Inc.
KPRX
$2.84
$0.1917.21%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.85% | 48.08% | -23.74% | -53.64% | -116.51% |
| Total Depreciation and Amortization | 60.71% | 12.64% | 22.54% | -20.67% | 10.49% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2.45% | 367.31% | -114.66% | 415.30% | 21.38% |
| Change in Net Operating Assets | -122.69% | -144.25% | -36.23% | 290.90% | -22,051.28% |
| Cash from Operations | -40.65% | -20.06% | -344.80% | 124.65% | -127.40% |
| Capital Expenditure | -- | -- | -- | 100.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -73.94% | 510.65% | 122.79% | 90.93% | -- |
| Cash from Investing | -75.15% | 453.72% | 125.14% | 90.95% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -98.48% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -100.00% | 100.09% |
| Cash from Financing | -- | -- | -- | -100.00% | -98.36% |
| Foreign Exchange rate Adjustments | 1,202.97% | 113.38% | -221.19% | 790.00% | 113.73% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -12,774.65% | 98.85% | -96.72% | 96.20% | -185.70% |